COMMUNIQUÉS West-GlobeNewswire

Nymox Annual Report

18/07/2024 - 19:24

IRVINE, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) announced today that its Annual Report is and has been in progress since late February, soon after Nymox [...]

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

18/07/2024 - 18:00

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – July 18, 2024 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven [...]

Invitation to Idorsia's Half Year 2024 Financial Reporting webcast and conference call

18/07/2024 - 17:45

Idorsia will publish its Half Year 2024 Financial Reporting on Thursday July 25, 2024, at 07:00 CEST. An investor conference call and webcast will be held to discuss the results on the same day. Date: Thursday, July 25 [...]

Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria

18/07/2024 - 17:35

HENDERSON, Nev., July 18, 2024 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA ) announces the signing of a distribution agreement for the Republic of Nigeria. The extensive negotiations with I.Conntact- [...]

ZyVersa Therapeutics Announces Publication Demonstrating that Inflammasome ASC Inhibitor IC 100 Restored Retinal Structure and Function in a Retinopathy of Prematurity Animal Model

18/07/2024 - 17:18

Publication showed that IC 100 suppressed retinal microglia activation by interfering with ASC speck formation, attenuating retinal inflammation, abnormal retinal vascularization, and retinal thinning, and it led to [...]

Signati Medical Announces Completion of Enrollment in First-in-Human Clinical Trial for Groundbreaking Sealed Vasectomy Procedure

18/07/2024 - 17:17

Providence, RI, July 18, 2024 (GLOBE NEWSWIRE) -- Signati Medical™, a medical device company dedicated to advancing men’s health, today announced the successful completion of enrollment in its Investigational Device [...]

Alkeus Pharmaceuticals Announces Presentation of a TEASE-3 Study Update Showing Progression Stalled in Early-Stage Stargardt Disease Patients Treated with Gildeuretinol

18/07/2024 - 16:20

Data in early-stage patients presented at 42nd ASRS Annual Scientific Meeting CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced the presentation of interim data from its [...]

Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3

18/07/2024 - 15:52

New Disruptive System With The Potential To Bring Life-Saving Technology To Every Corner Of The Planet To Be Unveiled in New York For An Exclusive Demonstration FORT LAUDERDALE, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- [...]

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

18/07/2024 - 15:15

The 30-patient study is designed to measure the efficacy of applying NEXGEL’s hydrogel during laser hair removal in eliminating harmful particles or plume during treatments Several states have already either instituted [...]

Bioxytran Launches Joint Venture with the Heme Foundation for Development of Universal Oxygen Carrier

18/07/2024 - 15:00

The Heme Foundation and Bioxytran join forces to address the global blood supply shortage BOSTON, MASSACHUSETTS, July 18, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage [...]

Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024

18/07/2024 - 15:00

Houston, Texas and Tuebingen, Germany, July 18, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer [...]

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

18/07/2024 - 15:00

Technology offers benefits of HeartFlow Plaque Analysis with the new addition of 3D interactive capabilities, integrated with lesion specific FFR CT values WASHINGTON, July 18, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc [...]

Signati™ Medical Enrolls First Patient in Groundbreaking Sealed Vasectomy Procedure Trial

18/07/2024 - 15:00

Providence, RI, July 18, 2024 (GLOBE NEWSWIRE) -- Signati Medical™, a medical device company dedicated to advancing men’s health, today announced the successful completion of enrollment in its Investigational Device [...]

Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

18/07/2024 - 14:45

MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening [...]

Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery

18/07/2024 - 14:30

‘Breaking Barriers’ Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting HOUSTON, TX, July 18, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: [...]

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

18/07/2024 - 14:30

As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women’s Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial BRAINTREE, Mass., July 18, 2024 ( [...]

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License Agreement

18/07/2024 - 14:30

Brad Hauser, Chief Executive Officer of Autonomix, discusses the Company’s agreement to license FDA-cleared ablation technology from RF Innovations, Inc. THE WOODLANDS, TX, July 18, 2024 (GLOBE NEWSWIRE) -- Autonomix [...]

Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility

18/07/2024 - 14:30

Company poised to execute additional cGMP activities throughout the remainder of the year DURHAM, N.C., July 18, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) , (“Scorpius” or the “Company”), an [...]

Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success

18/07/2024 - 14:30

NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]